ADIAL PHARMACEUTICALS, INC. (ADIL) Operating income 2017–2025
ADIAL PHARMACEUTICALS, INC. (ADIL) annual operating income history from SEC filings — each fiscal year as reported.
-$7.8MFY2025 · since FY2017: -$995,286 → -$7.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$7.8M | +5.9% |
| FY2024 | -$8.3M | -20.3% |
| FY2023 | -$6.9M | +36.6% |
| FY2022 | -$10.9M | +43.7% |
| FY2021 | -$19.3M | -76.5% |
| FY2020 | -$10.9M | -32.5% |
| FY2019 | -$8.2M | -18.0% |
| FY2018 | -$7.0M | -602.0% |
| FY2017 | -$995,286 | — |
Source: SEC XBRL filings · For reference only · Not investment advice